Kia ora Adam,
Thank you for your email. 
Novavax started their rolling application to Medsafe in August and the
data has been under evaluation. Medsafe has recently received a large
amount of data from Novavax, however there is more data and information
yet to be provided. As with other COVID-19 vaccines, Medsafe will
prioritise the review of this data. An announcement will be made
once Medsafe has made a decision on the application. 
 
Following Medsafe’s regulatory decision on the safety and effectiveness of
the Novavax COVID-19 vaccine and once delivery schedules have been
confirmed, we will consider the use of Novavax in New Zealand.   
 
So far, Medsafe has granted provisional approval for the Pfizer, Janssen
and AstraZeneca COVID-19 vaccines. 
 
Provisional approval means the pharmaceutical company must meet certain
conditions, including supplying more data from its clinical trials around
the world as they progress. Information about the approval process can be
found on
the Medsafe website: [1]https://www.medsafe.govt.nz/COVID-19/vac....
Medsafe approval is one step in the process for accessing a COVID-19
vaccine. Once approved, Cabinet then considers advice and makes decisions
on when and for who a particular vaccine will be used as part of the
COVID-19 immunisation programme. If or when Cabinet approves a 'decision
for use', this would determine how the Novavax vaccine would be used in
New Zealand.

Under section 28(3) of the Act you have the right to ask the Ombudsman to
review any decisions made under this request. The Ombudsman may be
contacted by email at: [2][email address] or by calling 0800
802 602. 

 

Ngâ mihi 

OIA Services Team 

  

[3]Ministry of Health information releases 

[4]Unite against COVID-19 

--------------------------------------------------------------------------

From: Adam Irish <[FOI #18128 email]>
Sent: Monday, 10 January 2022 13:30
To: OIA Requests <[email address]>
Subject: Official Information request - Novavax vaccine
 
Dear Ministry of Health,

Under the Official Information Act I request when will the Novavax vaccine
will become available. Additionally I request if it will be available as a
booster and the age ranges it will cover. Specifically will it also be
available for ages 5 to 12.

Yours sincerely

Adam

-------------------------------------------------------------------

This is an Official Information request made via the FYI website.

Please use this email address for all replies to this request:
[FOI #18128 email]

Is [Ministry of Health request email] the wrong address for Official Information requests
to Ministry of Health? If so, please contact us using this form:
[5]https://scanmail.trustwave.com/?c=15517&...

Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:
[6]https://scanmail.trustwave.com/?c=15517&...

If you find this service useful as an Official Information officer, please
ask your web manager to link to us from your organisation's OIA or LGOIMA
page.

show quoted sections

This e-mail message has been scanned for Viruses and Content and cleared
by the Ministry of Health's Content and Virus Filtering Gateway

--------------------------------------------------------------------------

References

Visible links
1. https://www.medsafe.govt.nz/COVID-19/vac...
2. mailto:[email address]
3. https://www.health.govt.nz/about-ministr...
4. https://covid19.govt.nz/
5. https://scanmail.trustwave.com/?c=15517&...
6. https://scanmail.trustwave.com/?c=15517&...